APA

DeVore R. F., Hellerqvist C. G., Wakefield G. B., Wamil B. D., Thurman G. B., Minton P. A., Sundell H. W., Yan H. P., Carter C. E., Wang Y. F., York G. E., Zhang M. H. & Johnson D. H. (19990218). Phase I study of the antineovascularization drug CM101. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

DeVore R F, Hellerqvist C G, Wakefield G B, Wamil B D, Thurman G B, Minton P A, Sundell H W, Yan H P, Carter C E, Wang Y F, York G E, Zhang M H and Johnson D H. 19990218. Phase I study of the antineovascularization drug CM101. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

DeVore R. F., Hellerqvist C. G., Wakefield G. B., Wamil B. D., Thurman G. B., Minton P. A., Sundell H. W., Yan H. P., Carter C. E., Wang Y. F., York G. E., Zhang M. H. and Johnson D. H. (19990218). Phase I study of the antineovascularization drug CM101. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

DeVore R F, Hellerqvist C G, Wakefield G B, Wamil B D, Thurman G B, Minton P A, Sundell H W, Yan H P, Carter C E, Wang Y F, York G E, Zhang M H and Johnson D H. Phase I study of the antineovascularization drug CM101. : Clinical cancer research : an official journal of the American Association for Cancer Research. 19990218.